Seyedmousavi Seyedmojtaba, Hashemi Seyed Jamal, Rezaie Sasan, Fateh Mohsen, Djavid Gholamreza Esmaeeli, Zibafar Ensieh, Morsali Farhad, Zand Nasrin, Alinaghizadeh Mohammadreza, Ataie-Fashtami Leila
1 Department of Medical Microbiology , Radboudumc, Nijmegen, The Netherlands .
Photomed Laser Surg. 2014 Jun;32(6):322-9. doi: 10.1089/pho.2012.3387.
The purpose of this study was to evaluate the effects of low-level laser irradiation (LLLI) on the in vitro growth characteristics and in vivo pathogenicity of Candida albicans in a murine model in the absence of a photosensitizer.
C. albicans is an opportunistic commensal organism that causes a wide variety of diseases in human beings, ranging from superficial infections to life-threatening invasive candidiasis. The incidence of C. albicans infection is increasing, because of the greater frequency of acquired immunodeficiency conditions. A high recurrence rate has been reported for vulvovaginal and oral candidiasis, despite the best available treatments. Therefore, the search for new treatment modalities seems quite rational.
Candida culture plates were exposed to common clinical energies of LLLI: 3, 5, 10, and 20 J at 685 nm (BTL Laser 5000, Medicinos Projektai, Czech Republic, Prague, max power output 50 mW) and 3, 5, 10, 30, and 50 J at 830 nm (BTL Laser 5000, Medicinos Projektai, Czech Republic, Prague, max power output 400 mW).
Following LLLI with energies >10 J at both 685 and 830 nm wavelengths, statistically significant effects were observed in vitro on the turbidimetric growth kinetics of C. albicans and in vivo on the survival rate of infected mice (p value ≤ 0.05). Therefore, this energy could be considered a threshold for clinical investigation.
Translating our data into the clinical setting, it can be proposed that a direct laser-based approach without using a photosensitizing dye can significantly reduce the pathogenicity of Candida albicans. It can also be concluded that laser light at specific wavelengths could be a possible promising novel treatment for superficial and mucocutaneous C. albicans infections.
本研究旨在评估在无光敏剂的情况下,低强度激光照射(LLLI)对白色念珠菌体外生长特性及在小鼠模型体内致病性的影响。
白色念珠菌是一种机会性共生菌,可导致人类多种疾病,从浅表感染到危及生命的侵袭性念珠菌病。由于获得性免疫缺陷疾病的发生率增加,白色念珠菌感染的发病率正在上升。尽管有最佳的现有治疗方法,但据报道外阴阴道念珠菌病和口腔念珠菌病的复发率很高。因此,寻找新的治疗方式似乎是合理的。
将念珠菌培养平板暴露于LLLI的常见临床能量下:685nm波长下为3、5、10和20J(BTL Laser 5000,Medicinos Projektai,捷克共和国布拉格,最大功率输出50mW),830nm波长下为3、5、10、30和50J(BTL Laser 5000,Medicinos Projektai,捷克共和国布拉格,最大功率输出400mW)。
在685nm和830nm波长下,当能量>10J进行LLLI后,在体外对白色念珠菌的比浊生长动力学以及在体内对感染小鼠的存活率均观察到统计学上的显著影响(p值≤0.05)。因此,该能量可被视为临床研究的阈值。
将我们的数据转化到临床环境中,可以提出一种不使用光敏染料的直接基于激光的方法能够显著降低白色念珠菌的致病性。还可以得出结论,特定波长的激光可能是治疗浅表和黏膜皮肤白色念珠菌感染的一种有前景的新型疗法。